Oregon Cancer

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

A new study focused on stories will change health outcomes for Black women.

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.

Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.

We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.

Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.

The study may redefine care for many people at the earliest stage of their treatment.

Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.

A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.

A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.

Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.

Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

Providence, Microsoft Research, University of Washington unveil GigaTIME, an AI-powered pathology breakthrough set to transform cancer immunotherapy research

Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.

Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.